Deutsche Telekom AG : Very little upside potential, so the risk for a correction is significant
Entry price | Target | Stop-loss | Potential |
---|
€16.43 |
€15.5 |
€16.7 |
+5.63% |
---|
After the strong price increase that has been seen over the past few weeks, it appears opportune to anticipate a correction phase for shares in Deutsche Telekom AG, as the resistance around 16.61 EUR approaches.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● Historically, the company has been releasing figures that are above expectations.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● The tendency within the weekly time frame is positive above the technical support level at 15.28 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 16.55.
● The stock is close to a major daily resistance at EUR 16.61, which should be gotten rid of so as to gain new appreciation potential.
● The group shows a rather high level of debt in proportion to its EBITDA.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.